Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical ... During the event, he will discuss recent findings from the Advance-HTN and Launch-HTN clinical trials, address the challenges ...

Mineralys Therapeutics (MLYS) announced that data from the Phase 2 Advance-HTN trial evaluating the efficacy and safety of lorundrostat for the treatment of uncontrolled hypertension or resistant ...

We recently compiled a list of the 10 Pump and Dump Stocks Favored by Hedge Funds. In this article, we are going to take a ...

In this article, we are going to take a look at where Mineralys Therapeutics, Inc. (NASDAQ:MLYS) stands against the pump and dump stocks ... edge through a combination of proprietary research, ...